Theramex’s Acquisition of Duphaston and Femoston Drugs From Viatris

Linklaters advises Theramex on the deal.Theramex (a portfolio company of Carlyle and PAI Partners) completed a proposed acquisition of certain rights and assets relating to the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here